Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Smoking Cessation in Opioid Treatment Patients
NCT03365362Phase 4Completed
- Sponsor
- Albert Einstein College of Medicine
- Start
- Oct 2018
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of varenicline in Tobacco Use Disorder (TUD), sponsored by Albert Einstein College of Medicine. Started Oct 2018; status: completed.
02
Drugs
varenicline
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT03365362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03365362.